Stock Scorer

Relay Therapeutics, Inc. (RLAY) · Insider trading

What Relay Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$130.22M
5 insiders, 9% under a plan
Net, 12 months
−$130.22M
bought less sold
Latest filing
2026-10-08
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-12: $527,431 sold 2025-01: $3.19M sold 2025-01 2025-02: $818,400 sold 2025-03: $18,162 sold 2025-04: $417,235 sold 2025-07: $542,926 sold 2025-07 2025-10: $683,119 sold 2025-11: $434,511 sold 2026-01: $724,355 sold 2026-01 2026-03: $178,233 sold 2026-04: $305,048 sold 2026-05: $227,841 sold 2026-06: $5.71M sold 2026-07: $1.52M sold 2026-07 2026-08: $117.82M sold 2026-09: $1.41M sold 2026-10: $1.20M sold
Bought Sold Largest month: $117.82M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Sb Investment Advisers (uk) Ltd10% owner – $116.40M 1 2026-08-25 –
Patel SanjivDirector, President and CEO – $7.96M 16 2026-10-07 471,301
Catinazzo ThomasChief Financial Officer – $6.00M 35 2026-10-06 105,340
Bergstrom Donald APresident, R&D – $2.96M 18 2026-09-08 399,130
Rahmer PeterSee remarks – $2.13M 21 2026-08-26 223,657
Adams BrianChief Legal Officer – $377,336 9 2025-07-29 371,472

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-10-07 Patel SanjivDirector, President and CEO Saleplan 48,199 18.10 $872,402 471,301 Form 4
2026-10-06 Catinazzo ThomasChief Financial Officer Saleplan 17,511 18.58 $325,354 105,340 Form 4
2026-10-06 Catinazzo ThomasChief Financial Officer Saleplan 206 19.26 $3,968 105,134 Form 4
2026-09-08 Patel SanjivDirector, President and CEO Saleplan 48,199 18.94 $912,889 519,500 Form 4
2026-09-08 Catinazzo ThomasChief Financial Officer Saleplan 17,717 18.94 $335,560 122,851 Form 4
2026-09-08 Bergstrom Donald APresident, R&D Saleplan 8,530 18.97 $161,814 399,130 Form 4
2026-08-26 Rahmer PeterSee remarks Saleplan 4,508 20.03 $90,295 223,657 Form 4
2026-08-25 Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M2) L.P., Svf Pauling (Cayman) Ltd Saleindirect 6,000,000 19.40 $116.40M 21,904,963 Form 4
2026-08-17 Patel SanjivDirector, President and CEO Saleplan 48,199 20.33 $979,886 567,699 Form 4
2026-08-14 Catinazzo ThomasChief Financial Officer Saleplan 17,717 19.74 $349,734 140,568 Form 4
2026-07-28 Bergstrom Donald APresident, R&D Sale 2,237 18.61 $41,631 407,660 Form 4
2026-07-28 Rahmer PeterSee remarks Sale 748 18.61 $13,920 228,165 Form 4
2026-07-28 Catinazzo ThomasChief Financial Officer Sale 1,459 18.61 $27,152 158,285 Form 4
2026-07-07 Patel SanjivDirector, President and CEO Saleplan 48,199 19.58 $943,736 615,898 Form 4
2026-07-06 Catinazzo ThomasChief Financial Officer Saleplan 17,717 18.69 $331,131 159,744 Form 4
2026-07-06 Bergstrom Donald APresident, R&D Saleplan 8,660 18.71 $162,029 409,897 Form 4
2026-06-30 Rahmer PeterSee remarks Saleplan 50,000 19.09 $954,500 225,857 Form 4
2026-06-22 Bergstrom Donald APresident, R&D Saleplan 93,456 16.94 $1.58M 418,557 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Saleplan 17,717 17.01 $301,366 177,461 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Saleplan 56,323 16.97 $955,801 177,461 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Saleplan 61,563 16.97 $1.04M 177,461 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Saleplan 51,560 16.97 $874,973 177,461 Form 4
2026-05-14 Catinazzo ThomasChief Financial Officer Saleplan 17,717 12.86 $227,841 195,178 Form 4
2026-04-28 Bergstrom Donald APresident, R&D Sale 1,490 14.79 $22,037 418,557 Form 4
2026-04-28 Rahmer PeterSee remarks Sale 753 14.79 $11,137 275,857 Form 4
2026-04-28 Catinazzo ThomasChief Financial Officer Sale 972 14.79 $14,376 212,895 Form 4
2026-04-09 Catinazzo ThomasChief Financial Officer Saleplan 1,800 15.00 $27,000 213,867 Form 4
2026-04-07 Catinazzo ThomasChief Financial Officer Saleplan 17,717 13.01 $230,498 213,867 Form 4
2026-03-09 Catinazzo ThomasChief Financial Officer Saleplan 17,717 10.06 $178,233 231,584 Form 4
2026-01-28 Catinazzo ThomasChief Financial Officer Sale 1,695 8.45 $14,323 249,301 Form 4
2026-01-28 Rahmer PeterSee remarks Sale 1,354 8.45 $11,441 276,610 Form 4
2026-01-28 Bergstrom Donald APresident, R&D Sale 2,686 8.45 $22,697 420,047 Form 4
2026-01-27 Catinazzo ThomasChief Financial Officer Sale 13,820 7.62 $105,308 250,996 Form 4
2026-01-27 Rahmer PeterSee remarks Sale 11,684 7.62 $89,032 277,964 Form 4
2026-01-27 Bergstrom Donald APresident, R&D Sale 18,895 7.62 $143,980 422,733 Form 4
2026-01-06 Patel SanjivDirector, President and CEO Sale 43,168 7.82 $337,574 661,041 Form 4
2025-11-03 Patel SanjivDirector, President and CEO Sale 62,073 7.00 $434,511 703,215 Form 4
2025-10-29 Rahmer PeterSee remarks Sale 21,394 7.50 $160,455 337,469 Form 4
2025-10-28 Bergstrom Donald APresident, R&D Sale 30,897 7.29 $225,239 521,823 Form 4
2025-10-28 Catinazzo ThomasChief Financial Officer Sale 21,664 7.29 $157,931 313,631 Form 4
60 more
2025-10-28 Rahmer PeterSee remarks Sale 19,135 7.29 $139,494 358,863 Form 4
2025-07-29 Adams BrianChief Legal Officer Sale 18,276 3.68 $67,256 371,472 Form 4
2025-07-29 Bergstrom Donald APresident, R&D Sale 26,701 3.68 $98,260 552,720 Form 4
2025-07-29 Catinazzo ThomasChief Financial Officer Sale 18,380 3.68 $67,638 335,295 Form 4
2025-07-29 Rahmer PeterSee remarks Sale 15,724 3.68 $57,864 377,998 Form 4
2025-07-28 Adams BrianChief Legal Officer Sale 1,637 3.74 $6,122 389,748 Form 4
2025-07-28 Bergstrom Donald APresident, R&D Sale 4,069 3.74 $15,218 579,421 Form 4
2025-07-28 Catinazzo ThomasChief Financial Officer Sale 1,701 3.74 $6,362 353,675 Form 4
2025-07-28 Rahmer PeterSee remarks Sale 1,359 3.74 $5,083 393,722 Form 4
2025-07-09 Patel SanjivDirector, President and CEO Sale 42,740 3.57 $152,582 783,927 Form 4
2025-07-09 Patel SanjivDirector, President and CEO Sale 18,639 3.57 $66,541 765,288 Form 4
2025-04-30 Adams BrianChief Legal Officer Sale 12,943 3.00 $38,829 391,385 Form 4
2025-04-30 Bergstrom Donald APresident, R&D Sale 27,472 3.00 $82,416 583,490 Form 4
2025-04-30 Catinazzo ThomasChief Financial Officer Saleplan 12,943 3.00 $38,829 355,376 Form 4
2025-04-30 Rahmer PeterSee remarks Sale 10,739 3.00 $32,217 390,081 Form 4
2025-04-29 Catinazzo ThomasChief Financial Officer Saleplan 3,558 3.23 $11,492 368,319 Form 4
2025-04-28 Adams BrianChief Legal Officer Sale 1,644 3.17 $5,211 404,328 Form 4
2025-04-28 Bergstrom Donald APresident, R&D Sale 4,090 3.17 $12,965 610,962 Form 4
2025-04-28 Catinazzo ThomasChief Financial Officer Saleplan 1,709 3.17 $5,418 372,858 Form 4
2025-04-28 Catinazzo ThomasChief Financial Officer Saleplan 981 3.17 $3,110 371,877 Form 4
2025-04-28 Rahmer PeterSee remarks Sale 1,364 3.17 $4,324 400,820 Form 4
2025-04-23 Patel SanjivDirector, President and CEO Sale 42,769 2.97 $127,024 840,320 Form 4
2025-04-23 Patel SanjivDirector, President and CEO Sale 18,653 2.97 $55,399 821,667 Form 4
2025-03-27 Adams BrianChief Legal Officer Sale 298 2.84 $846 405,972 Form 4
2025-03-27 Catinazzo ThomasChief Financial Officer Saleplan 298 2.84 $846 379,133 Form 4
2025-03-27 Catinazzo ThomasChief Financial Officer Saleplan 4,566 2.84 $12,967 374,567 Form 4
2025-03-27 Rahmer PeterSee remarks Sale 247 2.84 $701 402,184 Form 4
2025-03-27 Bergstrom Donald APresident, R&D Sale 986 2.84 $2,800 615,052 Form 4
2025-02-13 Patel SanjivDirector, President and CEO Sale 75,324 3.70 $278,699 883,089 Form 4
2025-02-11 Patel SanjivDirector, President and CEO Sale 140,182 3.85 $539,701 625,948 Form 4
2025-01-30 Adams BrianChief Legal Officer Sale 20,791 4.42 $91,896 406,270 Form 4
2025-01-30 Bergstrom Donald APresident, R&D Sale 30,823 4.42 $136,238 616,038 Form 4
2025-01-30 Catinazzo ThomasChief Financial Officer Saleplan 20,791 4.42 $91,896 379,431 Form 4
2025-01-30 Rahmer PeterSee remarks Sale 17,250 4.42 $76,245 402,431 Form 4
2025-01-29 Bergstrom Donald APresident, R&D Sale 46,407 4.55 $211,152 646,861 Form 4
2025-01-29 Catinazzo ThomasChief Financial Officer Saleplan 2,109 4.55 $9,596 400,222 Form 4
2025-01-29 Rahmer PeterSee remarks Sale 26,541 4.55 $120,762 419,681 Form 4
2025-01-28 Adams BrianChief Legal Officer Sale 33,688 4.63 $155,975 287,920 Form 4
2025-01-28 Bergstrom Donald APresident, R&D Sale 3,220 4.63 $14,909 516,868 Form 4
2025-01-28 Catinazzo ThomasChief Financial Officer Saleplan 33,753 4.63 $156,276 265,473 Form 4
2025-01-28 Catinazzo ThomasChief Financial Officer Saleplan 2,283 4.63 $10,570 263,190 Form 4
2025-01-28 Rahmer PeterSee remarks Sale 1,673 4.63 $7,746 307,081 Form 4
2025-01-23 Patel SanjivDirector, President and CEO Saleplanindirect 125,000 4.78 $597,500 199,548 Form 4
2025-01-22 Patel SanjivDirector, President and CEO Saleplanindirect 125,000 4.80 $600,000 324,548 Form 4
2025-01-21 Patel SanjivDirector, President and CEO Saleplanindirect 125,000 4.52 $565,000 449,548 Form 4
2025-01-06 Rahmer PeterSee remarks Saleplan 16,576 4.45 $73,763 308,754 Form 4
2025-01-03 Rahmer PeterSee remarks Saleplan 32,177 4.30 $138,361 325,330 Form 4
2025-01-02 Rahmer PeterSee remarks Saleplan 32,156 4.15 $133,447 357,507 Form 4
2024-12-27 Rahmer PeterSee remarks Sale 400 4.38 $1,752 389,663 Form 4
2024-12-27 Catinazzo ThomasChief Financial Officer Saleplan 299 4.38 $1,310 303,792 Form 4
2024-12-27 Catinazzo ThomasChief Financial Officer Saleplan 4,566 4.42 $20,182 299,226 Form 4
2024-12-27 Bergstrom Donald APresident, R&D Sale 657 4.38 $2,878 520,088 Form 4
2024-12-27 Adams BrianChief Legal Officer Sale 299 4.38 $1,310 321,608 Form 4
2024-12-16 Patel SanjivDirector, President and CEO Saleplanindirect 100,000 5.00 $500,000 574,548 Form 4
2024-10-29 Catinazzo ThomasChief Financial Officer Saleplan 2,300 5.95 $13,685 304,091 Form 4
2024-10-28 Adams BrianChief Legal Officer Sale 1,632 6.06 $9,890 321,907 Form 4
2024-10-28 Bergstrom Donald APresident, R&D Sale 2,688 6.06 $16,289 520,745 Form 4
2024-10-28 Catinazzo ThomasChief Financial Officer Saleplan 1,697 6.06 $10,284 311,496 Form 4
2024-10-28 Catinazzo ThomasChief Financial Officer Saleplan 5,105 6.06 $30,936 306,391 Form 4
2024-10-28 Rahmer PeterSee remarks Sale 1,621 6.06 $9,823 390,063 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

11 × grant or award5 × option exercise
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-06-30 Patel SanjivDirector, President and CEO Grant or award A +3,056 6.95 664,097 Form 4
2026-06-30 Rahmer PeterSee remarks Grant or award A +3,056 6.95 228,913 Form 4
2026-06-22 Bergstrom Donald APresident, R&D Option exercise M +93,456 4.12 512,013 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Option exercise M +56,323 5.04 233,784 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Option exercise M +61,563 5.22 239,024 Form 4
2026-06-22 Catinazzo ThomasChief Financial Officer Option exercise M +51,560 4.45 229,021 Form 4
2026-04-09 Catinazzo ThomasChief Financial Officer Option exercise M +1,800 5.22 215,667 Form 4
2025-12-31 Rahmer PeterSee remarks Grant or award A +994 2.99 338,463 Form 4
2025-12-31 Patel SanjivDirector, President and CEO Grant or award A +994 2.99 704,209 Form 4
2025-06-30 Patel SanjivDirector, President and CEO Grant or award A +5,000 2.94 826,667 Form 4
2025-06-30 Rahmer PeterSee remarks Grant or award A +5,000 2.94 395,081 Form 4
2025-02-11 Patel SanjivDirector, President and CEO Grant or award A +332,465 – 958,413 Form 4
2025-01-28 Adams BrianChief Legal Officer Grant or award A +139,141 – 427,061 Form 4
2025-01-28 Bergstrom Donald APresident, R&D Grant or award A +176,400 – 693,268 Form 4
2025-01-28 Catinazzo ThomasChief Financial Officer Grant or award A +139,141 – 402,331 Form 4
2025-01-28 Rahmer PeterSee remarks Grant or award A +139,141 – 446,222 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Relay Therapeutics's scores and multiples ›